Andrey Baranovsky

Clinical remission in patients with moderate-to-severe Crohn's disease treated with filgotinib (the FITZROY study): results from a phase 2, double-blind, randomised, placebo-controlled trial

Séverine Vermeire, Stefan Schreiber, Robert Petryka et al. · The Lancet · 2016 · 439 citations

Pharmacy, Clinical Sciences, Pharmacotherapy +13

Randomized, double-blind, controlled study of glycerol phenylbutyrate in hepatic encephalopathy

Don C. Rockey, John M. Vierling, Parvez Mantry et al. · Hepatology · 2013 · 162 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Clinical trial: A novel high-dose 1 g mesalamine suppository (salofalk) once daily is as efficacious as a 500-mg suppository thrice daily in active ulcerative proctitis

Tilo Andus, Andreas Kocjan, Moritz Müser et al. · Inflammatory Bowel Diseases · 2010 · 66 citations

Pharmacy, Internal Medicine, Pharmacotherapy +13

Drug-Induced Liver Injuries (Clinical Guidelines for Physicians)

Andrey Baranovsky, K. L. Raikhelson, М. V. Maevskaya et al. · Russian Journal of Gastroenterology Hepatology Coloproctology · 2019 · 64 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Morbidity and Mortality Rates from Digestive Diseases in the RF Northwestern Federal District (NWFD) and Measures to Reduce Them

Andrey Baranovsky · Russian Journal of Gastroenterology Hepatology Coloproctology · 2019 · 17 citations · Full text

Medicine, Internal Medicine, Cancer Epidemiology +16